| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.56B | $2.96B | $2.50B |
| YoY Revenue Growth % | +20.3% | +18.4% | — |
| Gross Profit | $1.16B | $1.01B | — |
| Gross Margin % | 32.6% | 34.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $697.3M | $639.1M | $587.1M |
| Operating Margin % | 19.6% | 21.6% | 23.5% |
| Net Income (GAAP) | $585.9M | $517.2M | $496.2M |
| EBITDA (Normalized) | $736.7M | $666.2M | $677.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $562.9M | $655.8M | $429.0M |
| Capital Expenditures (CapEx) | $49.3M | $33.9M | $112.5M |
| Free Cash Flow (FCF) | $513.6M | $621.9M | $316.5M |
| FCF Margin % | 14.4% | 21.0% | 12.7% |
| Return on Invested Capital (ROIC %) | 28.4% | 58.0% | 11.5% |
| Cash & Short-Term Equivalents | $952.6M | $693.5M | — |
| Total Debt (Short + Long Term) | $742.1M | $138.8M | $1.56B |
| Total Stockholders' Equity | $2.15B | $1.42B | $3.20B |